Diagnostics of Peripheral Arterial Disease Market Size, Share, Growth, and Industry Analysis, By Type (Ankle-Brachial Index (ABI), Ultrasonography, Angiography, Other), By Application (Hospital, Clinic, Other), Regional Insights and Forecast to 2035

Diagnostics of Peripheral Arterial Disease Market Overview

The Diagnostics of Peripheral Arterial Disease Market size valued at USD 975.02 million in 2026 and is expected to reach USD 1610.62 million by 2035, growing at a CAGR of 5.2% from 2026 to 2035.

The Diagnostics of Peripheral Arterial Disease Market is expanding rapidly due to rising prevalence of vascular disorders affecting nearly 202 million patients globally in 2025. Peripheral arterial disease (PAD) affects 12%–14% of adults above 55 years, with diagnostic adoption increasing by 18% in hospital vascular units. The Diagnostics of Peripheral Arterial Disease Market Report shows ABI devices dominate with 42% usage share, while ultrasound diagnostics account for 33% utilization. Increasing screening frequency by 25% in preventive healthcare systems is boosting demand. The Diagnostics of Peripheral Arterial Disease Market Analysis indicates early diagnosis reduces amputation risk by 70%, strengthening market penetration across 80+ countries.

In the USA, the Diagnostics of Peripheral Arterial Disease Market serves over 8.5 million diagnosed PAD patients and nearly 20 million undiagnosed high-risk individuals. Screening rates increased by 22% in outpatient vascular clinics and 15% in primary care centers. ABI testing is used in 68% of hospitals, while Doppler ultrasound usage stands at 54%. The Diagnostics of Peripheral Arterial Disease Market Outlook in the USA shows 35% of adults above 60 undergo vascular screening annually. Medicare-supported diagnostic procedures cover 70% of PAD testing. Rising diabetes prevalence affecting 37 million individuals further accelerates diagnostic demand growth across 6,000+ vascular care facilities.

Key Findings

• Key Market Driver: 12%–14% prevalence of PAD in adults above 55 years, 38% diabetes-linked cases, 29% hypertension contribution, 28% rise in screening adoption, and 24% increase in preventive vascular testing programs across healthcare systems globally.
• Major Market Restraint: 35% of small clinics face high equipment cost barriers, 18% shortage of vascular technicians, 30% rural access limitations, and 40% underdiagnosis rate globally reducing early detection efficiency in peripheral arterial disease diagnostics.
• Emerging Trends: 26% growth in AI-based vascular diagnostics, 31% rise in portable ABI devices, 25% expansion in telehealth screening, 62% shift toward non-invasive testing, and 45% increase in handheld Doppler adoption across outpatient care centers.
• Regional Leadership: North America holds 38% share, Europe 29%, Asia-Pacific 24%, Middle East & Africa 9%, with hospitals contributing 67% of diagnostics and clinics 33%, while ABI testing accounts for 42% of total procedures globally.
• Competitive Landscape: Top five companies control 52% of installations, ABI device segment holds 41% share, ultrasound systems 34%, innovation growth 19%, and AI-enabled diagnostic launches increased 22% across global vascular diagnostics market.
• Market Segmentation: ABI 42%, ultrasonography 33%, angiography 18%, others 7%. Hospitals 64%, clinics 28%, diagnostic centers 8%. Preventive screening contributes 46% of total diagnostic procedures globally.
• Recent Development: 21% increase in device launches, 27% growth in portable systems, 24% AI integration expansion, 25% telehealth screening growth covering 10 million patients, and 23% rise in hospital procurement of vascular diagnostic equipment worldwide.

Diagnostics of Peripheral Arterial Disease Market Latest Trends 

The Diagnostics of Peripheral Arterial Disease Market Trends show strong expansion of non-invasive diagnostic technologies, with ABI-based screening increasing by 34% in outpatient clinics. Ultrasonography adoption rose 29% due to improved imaging accuracy of 92% in detecting arterial stenosis. Portable diagnostic devices are gaining traction, with 31% growth in handheld Doppler usage across rural healthcare facilities.

AI-assisted vascular analysis tools are integrated into 22% of new diagnostic systems, improving detection speed by 40% compared to manual interpretation. Telehealth-based PAD screening programs expanded by 25% globally, enabling remote monitoring for over 10 million patients. The Diagnostics of Peripheral Arterial Disease Market Insights highlight increasing demand for early-stage detection, reducing amputation risk by up to 68%.

Hospitals account for 64% of total diagnostic procedures, while ambulatory care centers contribute 28%. Preventive screening programs expanded by 30% in cardiovascular risk groups. Diabetes-related PAD screening increased by 37% due to rising diabetic population of over 540 million globally. The Diagnostics of Peripheral Arterial Disease Market Forecast indicates increasing integration of wearable vascular monitoring devices, growing 21% annually in clinical trials across 45 countries.

Diagnostics of Peripheral Arterial Disease Market Dynamics

DRIVER:

Rising prevalence of vascular and diabetic disorders

The main driver of the Diagnostics of Peripheral Arterial Disease Market is the increasing prevalence of PAD, affecting 12%–14% of adults over 55 years. Diabetes contributes to 38% of PAD cases, while hypertension accounts for 29%. Screening programs expanded by 24% globally, improving early detection rates. Hospital-based vascular testing increased by 27% due to awareness campaigns. Over 20 million undiagnosed cases in developed economies drive diagnostic adoption. Preventive healthcare initiatives increased ABI testing utilization by 31% in primary care settings. Rising geriatric population growth of 18% further strengthens demand across healthcare infrastructure.

RESTRAINT:

High cost and limited accessibility

High diagnostic equipment costs restrict 35% of small healthcare facilities from adopting advanced PAD diagnostics. Technician shortages impact 18% of vascular testing centers. Rural accessibility limitations affect 30% of global patient population, delaying diagnosis by 6–12 months on average. Underdiagnosis rates remain high at 40%, reducing early intervention efficiency. Maintenance costs for imaging systems increased by 15%, limiting adoption in low-income regions. Insurance coverage gaps affect 22% of PAD screening procedures globally. These constraints collectively slow penetration of advanced diagnostic technologies in emerging healthcare markets.

OPPORTUNITY:

Expansion of portable and AI-based diagnostics

The Diagnostics of Peripheral Arterial Disease Market Opportunities are driven by portable ABI devices, which increased adoption by 31% globally. AI-based vascular imaging solutions are integrated into 22% of new diagnostic systems. Telemedicine expansion supports 25% growth in remote vascular screening. Mobile diagnostic units deployed in rural regions increased by 28%, improving access for underserved populations. Wearable vascular monitoring technologies show 21% annual adoption growth in pilot studies. Preventive screening programs expanded by 30% in cardiovascular risk groups, creating strong opportunities for manufacturers and healthcare providers.

CHALLENGE:

Technological complexity and workforce shortage

A major challenge is the 18% shortage of trained vascular technicians globally, limiting efficient diagnostics. Device calibration and maintenance complexity affects 26% of hospitals using advanced imaging systems. Integration of AI tools requires 40% additional training time for clinical staff. Interoperability issues impact 22% of diagnostic platforms across multi-vendor environments. Data management challenges affect 19% of healthcare institutions adopting digital vascular imaging. These challenges increase operational burden by 15% in diagnostic centers, slowing adoption rates in mid-tier hospitals and clinics.

Segmentation Analysis

By Type

• Ankle-Brachial Index (ABI): ABI testing represents 42% of total PAD diagnostics due to cost efficiency and 95% accuracy in detecting arterial blockage. Over 70% of primary care clinics use ABI devices, with screening rates increasing by 28% annually. Portable ABI systems account for 31% of new installations in rural healthcare setups. Preventive screening programs rely on ABI in 60% of cardiovascular risk assessments.
• Ultrasonography: Ultrasonography holds 33% market share with diagnostic accuracy reaching 92% in arterial flow detection. Doppler ultrasound usage increased by 29% in vascular labs. Hospitals account for 75% of ultrasound-based PAD testing. Real-time imaging capabilities improved diagnostic speed by 40%, supporting rapid clinical decision-making in emergency vascular cases.
• Angiography: Angiography contributes 18% of diagnostic procedures due to high-resolution imaging accuracy of 97%. It is primarily used in 45% of advanced vascular cases requiring surgical planning. Adoption increased by 17% in tertiary hospitals. Invasive procedure rates remain limited to 22% of total PAD diagnostics due to higher procedural complexity.
• Other Methods: Other diagnostic tools account for 7%, including photoplethysmography and emerging wearable devices. Adoption of wearable vascular monitoring increased by 21%. These tools are used in 18% of outpatient monitoring programs and support early detection in 25% of high-risk patients.

By Application

• Hospital: Hospitals dominate with 64% share of PAD diagnostics due to advanced imaging infrastructure. Over 85% of ABI and ultrasound procedures are conducted in hospitals. Diagnostic volumes increased by 27% due to rising cardiovascular admissions. Multi-specialty hospitals conduct 70% of angiography procedures.
• Clinic: Clinics account for 28% of diagnostics, primarily using ABI devices in 68% of cases. Ultrasound adoption in clinics increased by 22%. Outpatient vascular screening expanded by 30%, improving early detection rates in community healthcare systems.
• Other Applications: Other segments contribute 8%, including diagnostic labs and mobile health units. Mobile screening programs increased by 25% in rural regions. Preventive testing in workplace health programs expanded by 19% across developed economies.

Request a Free sample to learn more about this report.

Regional Outlook

North America 

North America dominates the Diagnostics of Peripheral Arterial Disease Market with 38% share, driven by over 8.5 million diagnosed PAD cases and 20 million high-risk individuals. The USA accounts for 85% of regional demand, with ABI usage in 68% of hospitals. Screening frequency increased by 22% in outpatient vascular clinics. Canada contributes 12% of regional demand, supported by 1,200 vascular centers. Mexico holds 3% share with expanding diagnostic infrastructure.

Ultrasonography usage in North America stands at 54%, while angiography accounts for 20% of procedures. Preventive screening programs expanded by 30% across cardiovascular risk populations. Diabetes prevalence of 37 million patients in the USA significantly drives demand. Portable diagnostic device adoption increased by 26%, particularly in rural clinics. Telehealth-based PAD screening programs grew by 24%, covering over 5 million patients annually. Hospital-based diagnostics represent 72% of regional procedures, while clinics account for 25%. The Diagnostics of Peripheral Arterial Disease Market Analysis indicates strong integration of AI-based vascular imaging in 28% of new installations.

Europe

Europe holds 29% share of the Diagnostics of Peripheral Arterial Disease Market, supported by structured screening programs across 27 countries. Germany leads with 24% regional share, followed by the UK at 18% and France at 15%. ABI testing is used in 62% of hospitals, while ultrasonography accounts for 48% of vascular diagnostics. Over 6 million patients in Europe are diagnosed with PAD, while 15 million remain at risk.

Preventive healthcare initiatives increased screening coverage by 27% across EU nations. Hospital-based diagnostics account for 70% of procedures. Angiography usage stands at 19% due to advanced vascular care facilities. Portable diagnostic devices adoption increased by 23% in rural European regions. AI integration in vascular imaging systems expanded by 21%. Diabetes prevalence of 61 million adults across Europe contributes significantly to PAD incidence. Clinics contribute 27% of diagnostic procedures. The Diagnostics of Peripheral Arterial Disease Market Outlook shows increased investment in non-invasive imaging systems across 1,800 vascular centers.

Asia-Pacific 

Asia-Pacific holds 24% share of the Diagnostics of Peripheral Arterial Disease Market, driven by rising diabetes cases exceeding 240 million individuals. China leads with 42% regional share, followed by India at 28% and Japan at 18%. ABI testing adoption increased by 29% in urban hospitals. Ultrasonography usage stands at 45% in tertiary healthcare centers.

Hospital-based diagnostics account for 66% of procedures, while clinics represent 30%. Rural healthcare expansion increased portable device usage by 33%. Preventive screening programs grew by 28% across cardiovascular risk populations. Angiography usage stands at 16% due to limited access in rural areas. AI-based diagnostic systems adoption increased by 19%. Over 4,500 vascular care centers operate across the region. Diabetes-related PAD screening increased by 34% due to high-risk population growth. The Diagnostics of Peripheral Arterial Disease Market Insights indicate rapid expansion in telemedicine-supported vascular diagnostics across 12 countries.

Middle East & Africa 

Middle East & Africa account for 9% of the Diagnostics of Peripheral Arterial Disease Market, with UAE, Saudi Arabia, and South Africa leading regional demand. UAE holds 28% of regional share, Saudi Arabia 26%, and South Africa 22%. Hospital-based diagnostics dominate with 78% share due to limited outpatient infrastructure.

ABI testing usage increased by 24% across urban hospitals. Ultrasonography accounts for 38% of diagnostics. Angiography usage remains at 14% due to limited advanced vascular facilities. Diabetes prevalence affecting 73 million individuals across the region significantly drives PAD diagnostics demand. Portable diagnostic adoption increased by 21% in rural areas.

Preventive screening programs expanded by 19% across government healthcare initiatives. AI-based imaging systems adoption remains at 12%, with increasing investments in 45 new vascular centers. Clinics account for 18% of diagnostic procedures. Mobile health units increased screening coverage by 17% in underserved regions. The Diagnostics of Peripheral Arterial Disease Market Forecast shows gradual improvement in vascular care infrastructure across 15 emerging economies.

List of Top Diagnostics of Peripheral Arterial Disease Companies

• Viasonix
• Koven Technology
• Natus Medical
• Huntleigh
• Hokanson
• CooperSurgical
• Perimed
• Atys Medical
• Newman Medical

Top 2 Companies (Highest Market Share)

• Viasonix– holds approximately 18% share in ABI diagnostic systems with deployment in 60+ countries and 12,000+ installed units
• Huntleigh– holds approximately 15% share in vascular diagnostic devices with 10,000+ clinical installations across 80 countries

Investment Analysis and Opportunities 

The Diagnostics of Peripheral Arterial Disease Market Investment Analysis shows increasing capital flow into non-invasive diagnostic technologies, with ABI device investments rising by 28% globally. Venture funding for vascular imaging startups increased by 22% across 2023–2025. Hospital procurement budgets allocated to PAD diagnostics expanded by 31% in developed healthcare systems.

Portable diagnostic device manufacturing investments increased by 26%, particularly in Asia-Pacific production hubs. AI-based vascular imaging startups attracted 19% more funding due to automation efficiency improvements of 40%. Telehealth diagnostics infrastructure expanded by 25% across 35 countries. Over 1,500 new vascular diagnostic units were installed globally in 2024 alone.

Manufacturers are investing in compact Doppler ultrasound systems, with production capacity expansion of 23% across leading firms. Emerging economies represent 34% of new investment opportunities due to rising diabetic population. Preventive screening programs funded by governments increased by 27%, supporting market expansion. The Diagnostics of Peripheral Arterial Disease Market Opportunities indicate strong demand for low-cost portable devices, expected to account for 38% of future installations.

New Product Development 

New product development in the Diagnostics of Peripheral Arterial Disease Market is focused on AI-enabled imaging systems, portable ABI devices, and wearable vascular monitors. AI integration in diagnostic tools increased by 24%, improving detection accuracy by 38%. Portable ABI devices now represent 31% of new product launches.

Wireless Doppler ultrasound systems expanded by 27% adoption in clinical trials. Wearable vascular sensors are being tested in 18% of cardiovascular monitoring programs. Smart diagnostic platforms integrating cloud analytics improved data processing speed by 42%. Over 60 new vascular diagnostic devices were launched globally between 2023 and 2025.

Battery-powered handheld diagnostic tools account for 35% of innovation pipelines. Miniaturized imaging systems reduced device size by 40%, increasing outpatient adoption. Digital vascular mapping technologies improved diagnostic precision by 29%. Hospitals adopting smart diagnostic systems increased by 26%. The Diagnostics of Peripheral Arterial Disease Market Trends indicate strong focus on automation, remote diagnostics, and AI-driven predictive analysis across 50+ countries.

Five Recent Developments (2023–2025)

1. ABI device manufacturers increased global installations by 21% in 2024 across 45 countries
2. AI-based vascular imaging systems adoption increased by 24% in hospital networks in 2025
3. Portable Doppler ultrasound devices expanded usage by 27% in rural healthcare centers in 2023
4. Telemedicine PAD screening programs grew by 25% covering 10 million+ patients in 2024
5. New vascular diagnostic product launches increased by 19% across global medical device companies

Report Coverage of Diagnostics of Peripheral Arterial Disease Market 

The Diagnostics of Peripheral Arterial Disease Market Report covers comprehensive analysis of diagnostic technologies including ABI systems, ultrasonography, angiography, and emerging wearable devices. The report evaluates over 50+ countries with structured segmentation across hospital, clinic, and diagnostic center applications. ABI devices account for 42% of total market coverage, while ultrasound systems represent 33% of analyzed technologies.

The Diagnostics of Peripheral Arterial Disease Market Research Report includes evaluation of 9 major companies and 100+ product variants across vascular diagnostics. Regional analysis spans North America with 38% share, Europe 29%, Asia-Pacific 24%, and Middle East & Africa 9%. The report assesses more than 8.5 million diagnosed PAD patients in the USA and 202 million globally.

Coverage includes technological trends such as AI integration in 22% of devices, portable diagnostics growth of 31%, and telehealth expansion affecting 25% of screening programs. The report also evaluates investment trends, showing 28% increase in funding for vascular diagnostics. Hospital-based diagnostics dominate with 64% share, while clinics account for 28%. The Diagnostics of Peripheral Arterial Disease Market Outlook provides insights into innovation pipelines, product launches, and adoption patterns across 1,000+ healthcare institutions worldwide.